OSE Immunotherapeutics SA
OSE · EURONEXT · EUR
€2.03
−0.05 −2.40%todayNot financial advice.
- Open
- 2.08
- Day range
- 2.03 - 2.09
- 52-week range
- 2.01 - 6.48
- Volume
- 43.3K
- Market cap
- 54.88M
- P/E ratio
- —
- EPS
- —
- Dividend yield
- 0.00%
- Beta
- 0.56
Performance
W
−5.14%
1M
−23.68%
3M
−36.44%
6M
−34.09%
YTD
−61.07%
Y
−66.50%
5Y
−79.82%
All
−81.38%
In the news
Oct 19
OSE Immunotherapeutics Phase 2 Trial Meets Main Goal in Lung Cancer Study
OSE Immunotherapeutics met its primary goal in a Phase 2 lung cancer study, showing improved one-year survival rates for its Tedopi combinations.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/EURONEXT-OSE" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="OSE Immunotherapeutics SA (OSE) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/EURONEXT-OSE">OSE stock price</a> by FreeTheAI Stocks</p>